These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8361550)

  • 21. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse.
    Stevens KE; Mickley GA; McDermott LJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1739-47. PubMed ID: 3737639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.
    Winkler M; Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):143-7. PubMed ID: 7199627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased calcium/calmodulin-dependent protein kinase II activity by morphine-sensitization in rat hippocampus.
    Kadivar M; Farahmandfar M; Ranjbar FE; Zarrindast MR
    Behav Brain Res; 2014 Jul; 267():74-82. PubMed ID: 24675163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters.
    Schnur P; Cesar SS; Foderaro MA; Kulkosky PJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):581-6. PubMed ID: 1784587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of morphine and phencyclidine in rats: the influence of repeated testing before and after single treatment.
    Van Ree JM; Leys A
    Eur J Pharmacol; 1985 Jul; 113(3):353-62. PubMed ID: 2931287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone reversal of morphine elicited hyperactivity.
    Schnur P; Hang D
    Life Sci; 1987 Jan; 40(4):329-33. PubMed ID: 3807637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opiate-induced turning in rats after injection into the ventral tegmental area.
    Szewczak MR; Spoerlein MT
    Pharmacol Biochem Behav; 1986 Nov; 25(5):959-65. PubMed ID: 3538063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone suppression and morphine enhancement of voluntary wheel-running activity in rats.
    Sisti HM; Lewis MJ
    Pharmacol Biochem Behav; 2001; 70(2-3):359-65. PubMed ID: 11701208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent effects of morphine and apomorphine on stereotyped gnawing in the hamster.
    Schnur P; Martinez RA
    Pharmacol Biochem Behav; 1989 Mar; 32(3):589-94. PubMed ID: 2662220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiating effect of morphine upon d-methamphetamine-induced hyperthermia in mice. Effects of naloxone and haloperidol.
    Funahashi M; Kohda H; Hori O; Hayashida H; Kimura H
    Pharmacol Biochem Behav; 1990 Jun; 36(2):345-50. PubMed ID: 2356207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locomotor activity of rats after injection of various opioids into the nucleus accumbens and the septum mediale.
    Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):175-80. PubMed ID: 3911070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of movement by morphine or haloperidol depends on an intact nucleus reticularis tegmenti pontis.
    Chesire RM; Cheng JT; Teitelbaum P
    Physiol Behav; 1983 May; 30(5):809-18. PubMed ID: 6878485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextro-naloxone counteracts amphetamine-induced hyperactivity.
    Chatterjie N; Sechzer JA; Lieberman KW; Alexander GJ
    Pharmacol Biochem Behav; 1998 Feb; 59(2):271-4. PubMed ID: 9476969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon as an endocoids candidate preventing and attenuating opiate addiction.
    Dafny N
    Prog Clin Biol Res; 1985; 192():269-76. PubMed ID: 4080713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of low doses of morphine on the activity of dopamine-containing cells and on behavior.
    Ostrowski NL; Hatfield CB; Caggiula AR
    Life Sci; 1982 Nov 15-22; 31(20-21):2347-50. PubMed ID: 7162350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.